Zymeworks BC Inc
ZYME
Market Cap$644.12M
Close$
$-8.88
198.3% downside
Current Fair Value
198.3% downsideOvervalued by 198.3% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $644.12 Million |
|---|---|
| Enterprise Value | $402.40 Million |
| Dividend Yield | $0.0 (0.0%) |
| Earnings per Share | $-4.06 |
| Beta | 0.0 |
| Outstanding Shares | 70,704,890 |
| Avg 30 Day Volume | 626,699 |
Return
| Return on Equity | - |
|---|---|
| Return on Assets | - |
| Return on Invested Capital | - |
Valuation & Multiples
| P/E Ratio | -2.72 |
|---|---|
| PEG | 63.22 |
| Price to Sales | - |
| Price to Book Ratio | 3.01 |
| Enterprise Value to Revenue | 12.72 |
| Enterprise Value to EBIT | -1.67 |
| Enterprise Value to Net Income | -2 |
| Total Debt to Enterprise | 0 |
| Debt to Equity | 0 |
Revenue Sources
No data
Insider Trades
ESG Score
No data
About Zymeworks Inc
CEO: Ali Tehrani